encepp

Retrospective Cohort Study on the Risk of Venous Thromboembolism with the use of combined oral contraceptives containing Chlormadinone Acetate/Ethinylestradiol and Levonorgestrel/Ethinylestradiol (RIVET-RCS)

14/04/2016
10/06/2024
EU PAS number:
EUPAS12171
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
ENCePP Seal
This study has been awarded the ENCePP seal
Conflicts of interest of investigators
English (921.51 KB - PDF) View document
Composition of steering group and observers
English (220.04 KB - PDF) View document
Signed code of conduct
English (65.32 KB - PDF) View document
Signed code of conduct checklist
English (279.16 KB - PDF) View document
Signed checklist for study protocols
English (399.88 KB - PDF) View document